益气养阴祛瘀方对NOD小鼠TLR-IFN-BAFF信号通路的调控作用
|
摘要
目的：观察益气养阴祛瘀方对NOD (non-obese diabetic)小鼠TLR-IFN-BAFF信号通路的调控作用,探讨益气养阴祛瘀方对干燥综合征的治疗作用及其机制,为其在临床上应用提供理论依据。
方法：将30只8周龄NOD小鼠随机分为3组,即模型组、羟氯喹组、益气养阴祛瘀方组(中药组),每组10只。ICR小鼠10只做为正常对照组。中药组每天按照27.4g/kg灌胃益气养阴祛瘀方；羟氯喹组按照每天75mg/kg灌胃羟氯喹。正常组和模型组正常饲养。实验期间每日记录小鼠平均饮水量,每周测定一次唾液分泌量。灌胃饲养12周后取血并处死小鼠,解剖分离脾脏、胸腺和颌下腺,计算脾脏、胸腺和颌下腺指数,光镜下观察各组小鼠颌下腺病理变化,酶联免疫法检测血清肿瘤坏死因子-α (Tumor necrosis factor-a, TNF-a)、白细胞介素-6(Interleukin-6, IL-6)、脱氢表雄酮(Dehydroepiandrosterone, DHEA)、雌二醇(Estrodio, E2)、免疫球蛋白G (Immunoglobulin G, IgG)水平,RT-PCR法检测外周血单个核细胞(Peripheral blood mononuclear cell, PBMC)中Toll样受体5(Toll like receptor5, TLR5)、 a-干扰素(Interferon-a, IFN-a)、 B淋巴细胞刺激因子(B-cell activating factor, BAFF) mRNA的表达,Western blot法检测脾脏和颌下腺组织TLR5、IFN-α、 BAFF蛋白的表达。
结果：①NOD小鼠发病后每日饮水量增加,唾液分泌量减少,脾脏指数增高,颌下腺指数降低,并伴颌下腺组织淋巴细胞浸润等病理损害。益气养阴祛瘀中药能增加NOD小鼠唾液分泌量,减少其每日饮水量,调节脾脏、胸腺和颌下腺指数,缓解颌下腺病理损害。②NOD小鼠血清TNF-α、IL-6、IgG水平升高,血清DHEA、E2水平降低。益气养阴祛瘀中药能降低NOD小鼠血清TNF-a. IL-6. IgG水平,升高血清DHEA. E2水平,对自身免疫性炎症有抑制作用,并能调节性激素水平。③NOD小鼠PBMC中TLR5、IFN-a. BAFFmRNA表达量增加；脾脏及颌下腺组织TLR5、IFN-a、BAFF蛋白表达水平升高。中药益气养阴祛瘀方能降低干燥综合征样NOD小鼠PBMC中TLR5、IFN-a、BAFFmRNA及脾脏、颌下腺组织TLR5、IFN-a、BAFF蛋白的表达。
结论：①益气养阴祛瘀方具有较好的改善NOD小鼠口干多饮症状及颌下腺组织病理损害、促进其分泌功能的作用。②益气养阴祛瘀方具有抑制炎症、调节免疫及性激素水平的作用。③益气养阴祛瘀方能下调TLR5、IFN-α、BAFFmRNA及蛋白的表达,调控TLR-IFN-BAFF信号通路,可能是治疗SS的作用机制之一④益气养阴祛瘀方是治疗NOD小鼠SS样病变较为有效的方法,值得进一步深入研究。
Objective To observe the effect of Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula on regulating TLR-IFN-BAFF signal pathway in NOD mice, and to explore the therapeutic effect and mechanism of Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula in treating Sjogren's syndrome, and offer experimental evidence for its clinncal application.
Methods Thirty NOD mice were randomized into three groups with10in each,i.e.model group,hydroxychloroquine group, Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula group(Chinese Herbs group). Take10ICR mice as normal control group. Chinese Herbs group were given27.4g·kg-1of Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula decoction every day. Hydroxychloroquine group were given hydroxychloroquine75mg-kg-1by gavage. Mice of normal group and model group were given nomal saline. Average drinking amount of water every mouse were recorded per day and salivary secretory volume were determined per weeks.Mice were sacrificed after drawing blood from the femoral artery after12weeks, taking thymus, submaxillary glands, spleen and calculating organs index. Pathological changes of submaxillary glands were observed under light microscope.The levels of TNF-a, IL-6, DHEA, E2, IgG in serum were detected by ELISA.Expression of TLR5, IFN-a, BAFF mRNA in peripheral blood mononuclear cells were detected using reverse transcriptase polymerase chain reaction(RT-PCR).Expression of TLR5, IFN-a, BAFF protein in spleen and submaxillary glands were detected by western blot.
Results①The amount of daily water intake increase, salivary secretory volume decrease, Spleen index rise, thymus and submaxillary glands index was reduced in NOD mice, with pathological damage in submaxillary glands, ie lymphocytic infiltration. Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can increase the salivary secretory volume, decrease the amount of daily water intake of NOD mice, regulat the index of Spleen, and thymus and submaxillary glands, alleviate the pathological damage in submaxillary glands.②The levels of TNF-a, IL-6, IgG in serum rise, the levels of DHEA, E2in serum decrease in NOD mice. Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can reduce the levels of TNF-a, IL-6, IgG in serum, promote the levels of DHEA, E2in serum, which can inhibition autoimmune inflammation, regulae the levels of sex steroids.③Expression of TLR5, IFN-a, BAFF mRNA in peripheral blood mononuclear cells and TLR5, IFN-a, BAFF protein in spleen and submaxillary glands in NOD mice increase. Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can reduce expression of. TLR5, IFN-a, BAFF in PBMC, spleen and submaxillary glands.
Conclusions①Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can improve the symptom and pathological damage in submaxillary glands, promote secretion function of submaxillary glands.②Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can depress inflammation, regulate immunologic function and the levels of sex steroid.③Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can decrease expression of TLR5, IFN-a, BAFF mRNA and protein, regulate and control TLR-IFN-BAFF signal pathway, which may be one of the mechanisms in treatment of Sjogren's syndrome.④Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula is an effective measure in treatment of Sjogren's syndrome in NOD mice and is worth further studying.
方法：将30只8周龄NOD小鼠随机分为3组,即模型组、羟氯喹组、益气养阴祛瘀方组(中药组),每组10只。ICR小鼠10只做为正常对照组。中药组每天按照27.4g/kg灌胃益气养阴祛瘀方；羟氯喹组按照每天75mg/kg灌胃羟氯喹。正常组和模型组正常饲养。实验期间每日记录小鼠平均饮水量,每周测定一次唾液分泌量。灌胃饲养12周后取血并处死小鼠,解剖分离脾脏、胸腺和颌下腺,计算脾脏、胸腺和颌下腺指数,光镜下观察各组小鼠颌下腺病理变化,酶联免疫法检测血清肿瘤坏死因子-α (Tumor necrosis factor-a, TNF-a)、白细胞介素-6(Interleukin-6, IL-6)、脱氢表雄酮(Dehydroepiandrosterone, DHEA)、雌二醇(Estrodio, E2)、免疫球蛋白G (Immunoglobulin G, IgG)水平,RT-PCR法检测外周血单个核细胞(Peripheral blood mononuclear cell, PBMC)中Toll样受体5(Toll like receptor5, TLR5)、 a-干扰素(Interferon-a, IFN-a)、 B淋巴细胞刺激因子(B-cell activating factor, BAFF) mRNA的表达,Western blot法检测脾脏和颌下腺组织TLR5、IFN-α、 BAFF蛋白的表达。
结果：①NOD小鼠发病后每日饮水量增加,唾液分泌量减少,脾脏指数增高,颌下腺指数降低,并伴颌下腺组织淋巴细胞浸润等病理损害。益气养阴祛瘀中药能增加NOD小鼠唾液分泌量,减少其每日饮水量,调节脾脏、胸腺和颌下腺指数,缓解颌下腺病理损害。②NOD小鼠血清TNF-α、IL-6、IgG水平升高,血清DHEA、E2水平降低。益气养阴祛瘀中药能降低NOD小鼠血清TNF-a. IL-6. IgG水平,升高血清DHEA. E2水平,对自身免疫性炎症有抑制作用,并能调节性激素水平。③NOD小鼠PBMC中TLR5、IFN-a. BAFFmRNA表达量增加；脾脏及颌下腺组织TLR5、IFN-a、BAFF蛋白表达水平升高。中药益气养阴祛瘀方能降低干燥综合征样NOD小鼠PBMC中TLR5、IFN-a、BAFFmRNA及脾脏、颌下腺组织TLR5、IFN-a、BAFF蛋白的表达。
结论：①益气养阴祛瘀方具有较好的改善NOD小鼠口干多饮症状及颌下腺组织病理损害、促进其分泌功能的作用。②益气养阴祛瘀方具有抑制炎症、调节免疫及性激素水平的作用。③益气养阴祛瘀方能下调TLR5、IFN-α、BAFFmRNA及蛋白的表达,调控TLR-IFN-BAFF信号通路,可能是治疗SS的作用机制之一④益气养阴祛瘀方是治疗NOD小鼠SS样病变较为有效的方法,值得进一步深入研究。
Objective To observe the effect of Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula on regulating TLR-IFN-BAFF signal pathway in NOD mice, and to explore the therapeutic effect and mechanism of Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula in treating Sjogren's syndrome, and offer experimental evidence for its clinncal application.
Methods Thirty NOD mice were randomized into three groups with10in each,i.e.model group,hydroxychloroquine group, Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula group(Chinese Herbs group). Take10ICR mice as normal control group. Chinese Herbs group were given27.4g·kg-1of Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula decoction every day. Hydroxychloroquine group were given hydroxychloroquine75mg-kg-1by gavage. Mice of normal group and model group were given nomal saline. Average drinking amount of water every mouse were recorded per day and salivary secretory volume were determined per weeks.Mice were sacrificed after drawing blood from the femoral artery after12weeks, taking thymus, submaxillary glands, spleen and calculating organs index. Pathological changes of submaxillary glands were observed under light microscope.The levels of TNF-a, IL-6, DHEA, E2, IgG in serum were detected by ELISA.Expression of TLR5, IFN-a, BAFF mRNA in peripheral blood mononuclear cells were detected using reverse transcriptase polymerase chain reaction(RT-PCR).Expression of TLR5, IFN-a, BAFF protein in spleen and submaxillary glands were detected by western blot.
Results①The amount of daily water intake increase, salivary secretory volume decrease, Spleen index rise, thymus and submaxillary glands index was reduced in NOD mice, with pathological damage in submaxillary glands, ie lymphocytic infiltration. Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can increase the salivary secretory volume, decrease the amount of daily water intake of NOD mice, regulat the index of Spleen, and thymus and submaxillary glands, alleviate the pathological damage in submaxillary glands.②The levels of TNF-a, IL-6, IgG in serum rise, the levels of DHEA, E2in serum decrease in NOD mice. Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can reduce the levels of TNF-a, IL-6, IgG in serum, promote the levels of DHEA, E2in serum, which can inhibition autoimmune inflammation, regulae the levels of sex steroids.③Expression of TLR5, IFN-a, BAFF mRNA in peripheral blood mononuclear cells and TLR5, IFN-a, BAFF protein in spleen and submaxillary glands in NOD mice increase. Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can reduce expression of. TLR5, IFN-a, BAFF in PBMC, spleen and submaxillary glands.
Conclusions①Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can improve the symptom and pathological damage in submaxillary glands, promote secretion function of submaxillary glands.②Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can depress inflammation, regulate immunologic function and the levels of sex steroid.③Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula can decrease expression of TLR5, IFN-a, BAFF mRNA and protein, regulate and control TLR-IFN-BAFF signal pathway, which may be one of the mechanisms in treatment of Sjogren's syndrome.④Strengthening Qi, Nourishing Yin and Removing Blood Stasis Formula is an effective measure in treatment of Sjogren's syndrome in NOD mice and is worth further studying.
引文
[1]Edward D,Harris Jr,Gary S Firestein,JohnS,Sergent,等.凯利风湿病学[M].北京：人民卫生出版社,2006,12：944.
[2]赵岩,董怡.原发性干燥综合征的临床分析[J].北京医学,1997,19(2):100-104.
[3]Manthorpe R.Primary Sjogren's syndrome:diagnosic criteria,clinical features and disease activity [J]..J Rhematol,1997,24(suppl):50.
[4]Tsubota K, Hirai S, King LS,et al.Defective cellular trafficking of lacrmal gland aquaporin-5 in Sjogren's syndrome [J].Lancet,2001,357(9257):688-689.
[5]Nikolay P. Nikolov and Gabor G. Illei. Pathogenesis of Sjogren's syndrome [J]. Current Opinion in Rheumatology 2009,21(5):465-470.
[6]Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren's syndrome [J].. ArchIntern Med.2004;164(12):1275-1284.
[7]王新昌,谢志军,温成平等.益气养阴祛瘀法治疗原发性干燥综合征的疗效观察[J].中国基层医学,2009(1):92-95.
[8]王新昌,谢志军,温成平等.益气养阴祛瘀药对干燥综合征患者性激素水平影响的研究[J].浙江中医药大学学报,2009(1):48-50.
[9]Fox RI, T heofilopoulos AN. Sjogren's syndrome:pathogensis and prospects for therapy [J]. Exp Opin Invest Drugs,1996,5:1.
[10]Gottenberg JE,Busson M,LoiseauP,etal.In primary Sjogren's syndrome,HLA classⅡ is associated exclusively with autoantibody production and spreading of the autoimmune response [J].Arthritis Rheum,2003,48(8):2240-2245.
[11]Fye KH,Terasaki PI,Moutspous H,et al.Assiciation of Sjogren's syndrome with HLA-B8 [J].Arthritis Rheum,1976,19:883.
[12]Johnson EO, Skopouli FN, Moutsopoulos HM. Neuroendocrine manifestations in Sjogren's syndrome [J]. Rheum Dis Clin North Am,2000,26 (4):927-949.
[13]孙文闻,巩路.雌激素在干燥综合征发病中的作用[J].国外医学内科学分册,2006,33(6)：245-248.
[14]Salem ML, Hossain MS, Nomoto K [J].Int Arch Allergy Immunol,2000,121 (3):235-245.
[15]张水艳.干燥综合征的中医病因病机及辨证治疗[J].中医杂志,2009,50(5)：468-470.
[16]Ishimaru N, Arakaki R, Yoshida S, et al. Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy [J]. J Exp Med 2008; 205:2915-2927.
[17]Nagler RM, Pollack S. Sjogren's syndrome induced by estrogen therapy [J]. Sem in Arthritis Rheum,2000 Dec;30(3):209-214.
[18]林良夫.雌激素水平下降引发干燥综合征[J].中华中医药学刊,2009,27(1)： 157.
[19]Konttinen YT, Fuellen G, Bing Y, et al. Sex steroids in Sjogren's syndrome [J]. J Autoimmun 2012 Aug; 39(1-2):49-56.
[20]Sullivan DA, Belanger A, Cermak JM,et al Are women with Sjogren's syndrome androgen-deficient [J]. J Rheumatol.2003 Nov; 30(11):2413-2419
[21]Beeson PB.Age and sex associations of 40 autoimmune disease [J].Am J Med,1994,96:457-462.
[22]Ishimaru N, Saegusa K, Yanagi K, Haneji N, Saito I, Hayashi Y:Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis [J]. Am J Pathol,1999,155:173-181.
[23]Sato TO, E.H.& D.A. Sullivan. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome [J]. Invest. Ophthalmol. Vis. Sci,1994,35: 2632-2642.
[24]Valtysdottir ST,et al. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function [J]. J. Rheumatol,2001,28:1259-1265.
[25]Laine M, Porola P, Udby L, et al. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome [J]. Arthritis Rheum.2007;56:2575-2584.
[26]Laine M. et al.2004. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome [J]. Arthritis Rheum.50:3968-3973.
[27]Taiym S, Haghighat N, Al-Hashimi I. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2004 May; 97(5):579-83.
[28]ITtah M, Miceli-Richard C, Gottenberg JE, et al. B-cell activating factor of the tumor necrosis factor family(BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome [J].Arthritis Res Ther, 2006,8:R51.
[29]Skapenko A, Schulze-Koops H.Analysis of Thl/Th2 T-cell subsets [J].Methods Mol Med,2007,136 (5):87-96.
[30]Liblau RS,Singer SM,McDevitt HO. Thl Aand Th2 CD4+ T-cell in the pathogenesis of organ-specific autoimmune disease [J].Immunol Today,1995,16: 34-38.
[31]唐福林.原发性干燥综合征的发病机制[J].中华风湿病学杂志,2000,4(1):50-53.
[32]蒋明,David YU,林孝义,等.中国风湿病学[M].北京：华夏出版社,2004,8：845.
[33]卢家俐,赵铖.羟基氯喹在风湿性疾病中的应用进展[J]. Internal Medicine of China,2008,3(1):69-70.
[34]Dawson LJ, Caulfied VL, Stanbury JB, et al.Hydroxychloroquine therapy in patients with primary Sjogren's syndrome may improve salivary gland Hypofunotion by inhibition of glangular cholinesterase [J].Rh eum atology,2005,44 (4):449-455.
[35]帅世全,孙红兵.羟氯喹治疗原发性干燥综合征的临床观察[J].西部医学,2011.23(7)：1281-1283.
[36]路志正,焦树德.痹病论治学[M].北京：人民卫生出版社,1989：281.
[37]姜泉,殷海波,张香妮,等.78例原发性干燥综合征患者中医证候分析[J].中华中医药杂志,2011,26(10):2402-2404.
[38]郝伟欣,董振华.干燥综合征106例中医证候分类回顾性研究[J].中医杂志,2006,(7)：528-529.
[39]宁康健,阮样春,吕锦芳.黄芪对小鼠腹腔巨噬细胞吞噬能力的影响[J].中国中药杂志,2005.30(21)：1670-1672.
[40]赵磊,蒲小平.丹参粉针剂对大鼠心肌缺血/再灌注损伤的保护作用[J].中国新药杂志,2006,15(14)：39-41.
[41]李嫒,宋宝安,杨松,等.中草药玄参化学成分的研究[J].天然产物研究与开发,2012,,24：47-51.
[42]王洪志,刘朝东,韦超.白芍总苷对慢性非细菌性前列腺炎大鼠IFN-γ、 TNF-a和IL-10表达影响的实验研究[J].重庆医科大学学报,2010,35(2)：231-234.
[43]韩凤梅,刘春霞,陈勇.麦冬多糖对免疫低下小鼠的保护作用[J].中国医药学报,2004,19(6)：347.
[44]沈玉先,魏伟,徐叔云,等.白芍总甙的药理作用及机制[A].吴曙光.抗炎免疫药理学进展[M].上海：第二军医大学出版社,1997.162-167.
[45]梁君山,魏伟,周爱武.白细胞介素1的检测及白芍总甙对其产生的影响[J].中国药理学通报,1989,5(6)：354-357.
[46]查学强,王军辉,潘利华,等.石斛多糖体外抗氧化活性的研究[J].食品科学,2007,28(10)：90-93.
[47]李钦,陈爱君,张信岳.铁皮石斛颗粒增强免疫功能作用研究[J].中药药理与临床,2008,24(1)：53-55.
[48]叶庆华,赵维民,秦国伟.石斛属植物化学成分及生物活性研究进展[J].药物化学进展,2004(3)：113.
[49]陈照荣,来平凡,林巧,等.不同炮制方法对石斛中石斛碱和多糖溶出率的影响[J].浙江中医学院学报,2002,26(4)：79.
[50]徐杭民,侯家玉.中药药理学[M].北京：中国中医药出版社,2002:157-158.
[51]Yoshiyo H, Mitsunobu S, Katsuiku H.Induction of experimental allergic sialodenitis in mice [J].Am J Pathol,1985,118:476-483.
[52]Greiner DL, Angelillo M, Wayne AL, et al.Experimental autoallergic sialodenitis in the LEW rat.Ⅲ Role of CD4+ T cells in EAS induction [J].Cell Immunol,1991,135:354-359.
[53]Mya Mu, Dipshikha C, Kazuko T, et al.Production of experimental autoimmune sialodenitis in mice immunized with homologous salivary gland extract and klebsiella O3 lipopolysaccharide [J].J Autoimmunity,2001,16:29-36.
[54]Suzuki K, Makino M, Okada Y, et al.Exocrinopathy resembling Sjogren's syndrome induced by a murine retrovirus[J].Lab Invest,1993,69:430-435.
[55]Yoshiyo H, Yashiaki Y, Hideo Y, et al.Development of allergic sialodenitis in mice immunized with mumps virus-infected submandibular salivary gland [J].Am J Pathol,1986,123:271-279.
[56]Van Blokland SC, Van Helden-Meeuwsen CG, Wierenga-Wolf AF, et al.Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjogren's syndrome:limited role for apoptosis in the development of sialoadenitis [J].Lab Invest,2003Jan,83 (1):3-11.
[57]Humphrey-Beher MG, Hu Y, Nakagawa Y, Wang PL, et al.Utilization of then non-obese diabetic(NOD) mouse as an animal model for the study of secondary Sjogren's syndrome [J].Adv Exp Med Biol,1994,350:631-636.
[58]Yamano S, Atkinson JC, Baum BJ, et al. salivary gland cytokine gene expression in NOD and BALB/c mice [J].Autoimmunity,1999,92,:265-275.
[59]Cha S, Peck AB, Humphreys-Beher MG, et al.Progress in understanding autoimmune exoc finopathy using the non-obese diabetic mouse:anupate [J].Cfit Rev Oral Biol Med,2002,13 (1):5-16.
[60]颜淑敏,曾小峰.原发性干燥综合征诊治进展[J].实用医院临床杂志,2007(3)：6-8.
[61]黄桂红,黄纯真,黄仁彬.阳桃根多糖对糖尿病小鼠胰岛素及胸、脾指数的影响[J].2009,,12(7)：848-850.
[62]曾靖,邱峰.大豆苷元对免疫器官的影响[J].赣南医学院学报,2004,24(2)：117-118.
[63]Rock F,Hardiman G,Timans J, et al. A family of human receptors structurally related to Drosophila Toll [J]. Proc Natl Acad Sci,1998,95 (2):588-593.
[64]Hans M,Hans V M.Toll-like receptors and their dual role in periodontitis:a review [J].J Oral Sci,2011,53 (3):263-271.
[65]Pasare C,Medzhitov R.Toll-like receptors:linking innate and adaptiveimmunity [J].Adv Exp Med Biol,2005,560:11-18.
[66]Werling D,Jann O C,Offord V,et al. Variation matters:TLR structure and species-specific pathogen recognition [J].Trends Immunol,2009,30(3):124-130.
[67]Runblom L, Alm GV. An etiopathogenic role for the type I IFN system in SLE [J]. Trends Immunol,2001,22(8):427-431.
[68]Hunziker L, Recher M, Macpherson AJ, et al. Hypergammaglobu-linemia and autoantibody induction mechanisms in viral infections [J].Nat Immunol,2003,4(4):343-349.
[69]KawakamiA, NakashimaK, TaxnaiM, et al. Toll-like receptor in salivary glands from Patients with Sjogren's syndrome:functional analysis by human salivary glands cell line [J]. J Rheumatol,2007,34(5):1019-1026.
[70]SPaehidouMP,BourazoPoulou E, Maratheftis Cl, et al. Expression of functional Toll-like Receptors by salivary gland epithelial cells:increased mRNA expression in cells derived from Patients with Primary Sjogren's syndrome [J]. Clin ExP immunol.2007,147(3):497-503.
[71]Ronnblom L,Gunnar VA. A pivotal role for the natural interferon-a-pro-ducing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus cing cells [J].J Exp Med,2001,12:F59-F63.
[72]Bave U, Nordmark G, Lovgren T, et al. Activation of the type I interferon system in primary Sjogren's syndrome:a possible etiopathogenic mechanism [J]. Arthritis Rheum 2005; 52:1185-1195.
[73]Hjelmervik TO, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy controls [J]. Arthritis Rheum 2005; 52:1534-1544.
[74]Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome [J]. Proc Natl Acad Sci U S A 2006; 103:2770-2775.
[75]Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjogren's syndrome [J]. Genes Immun 2009; 10:285-296.
[76]Lavie F, Miceli-Richard C, Ittah M, et al. -cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren's syndrome [J].Scand J Immunol,2008,67(2):185-192.
[77]Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome [J].Arthritis Rheum,2007,56(11):3588-3600.
[78]Mavragani CP, Niewold TB, Moutsopoulos NM, et al. Augmented interferon- alpha pathway activation in patients with Sjogren's syndrome treated with etanercept [J].Arthritis Rheum,2007,56(12):3995-4004.
[79]Moore PA,Belvedere 0,0 rr A,el al. BLyS:member of the tumor necrosis factor family and B lymphocyte stimulator [J].Science,1999,285(5425):260-263.
[80]Mackay F, Figgett WA, Saulep D, et al. B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor [J].Immunol Rev,2010,237(1):205-225.
[81]Groom J,Kalled SL,Cutler AH, et al. association of BAFF/BLyS over-expression and altered B cell differentiation with Sjogren's syndrome [J].J.Clin.Invest.2002,109(1):59-68.
[82]Szodoray P, Jellestad S, Teague MO, et al. Attenuated apoptosis of B cell activating factor-expressing cell in primary Sjogren's syndrome [J].Lab Invest,2003, 83(3):357-365.
[83]Lavie F,Miceli-Richacd C,QlIillard J,et a 1.Expression of BAFF in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome [J].J PatIlol,2004,202:496-502.
[84]Mariette x,Roux S,Zhang J,et al. The level of BlyS(BAFF) correlates with the tire of autoantibodies in human Sjogren's syndrome [J].Ann Rheum Dis,2003,62:168-171.
[85]Candon S, Gottenberg JE, Bengoufa D, et al. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren's syndrome:correlation with B-cell biomarkers and disease activity [J].Ann Rheum Dis,2009,68(7):1208-1212.
[86]Fox RI. Sjogren's syndrome [J].Lancet,2005,366(9482):321-331.
[87]Nikolov NP, Illei GG, Pathogenesis of Sjogren's syndrome [J].Curr Opin Rheumatol,2009;21(5):465-470.
[88]James J A, Harley J B, Scofield R H, Role of virus in systemic lupus erythematosus and Sjogren's syndrome[J]. Curr Opin Rheumatol,2001;13(5):370-376.
[89]Gujer C, Sundling C, Seder R A, et al. Human and rhesus plasmacytoid dendrtic cell and B-cell responses to Toll-like receptor stimulation [J].Immunology, 2011,134(3):257-269.
[90]Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type I interferon-producing cells in human blood [J]. Science 1999;284:1835-7.
[91]Perl A. Pathogenic mechanisms in systemic lupus erythematosus [J].Autoimmunity,2010,43(1):1-6.
[92]Komatsuda A, Wakui H, Iwamoto K, et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemi lupus erythematosus [J].Clin Exp Immunol,2008,152(3):482-487.
[93]Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, et al. Systemic increase in type I interferon activity in Sjogren's syndrome:a putative role for plasmacytoid dendritic cells [J]. Eur J Immunol,2008,38:2024-2033.
[94]Zhou L,Zhong R,Hao W,et al.Interleukin-10 and interferon-gamma up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells [J].Exp Mol Pathol,2009,87(1):54-58.
[95]Ittah M, Miceli-Richard C, Eric Gottenberg J, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome [J].Arthritis Res Ther,2006,8(2):51.
[96]Tobon GJ, Pers JO, Youinou P, et al. B cell-targeted therapies in Sjogren's syndrome [J].Autoimmun Rev,2010,9(4):224-228.
[1]Fox RI. Sjogren's syndrome [J].Lancet,2005,366:321-331.
[2]Shen Hu, Jianghua Wang, Jiska Meijer, etal.Salivary Proteomic and Genomic Biomarkers for Primary Sjogren's syndrome [J].Arthri-tisRheum,2007 November, 56 (11):3588-3600.
[3]Venables PJW.Sjogren's syndrome.Best Practice and Research [J].Clinical Rheumatology,2004,18 (3):313-329.
[4]钱垠,金实.从肺论治干燥综合征[J].南京中医药大学学报,2002,18(5):268-269.
[5]母小真.陈湘君治疗干燥综合征的经验[J].辽宁中医杂志,2002,29(1)：11.
[6]谢幼红.从脾论治干燥综合征的探讨[J].陕西中医,2010,31(6):710-711.
[7]陆瑾.陆安康教授治疗干燥综合征经验精粹[J].中医药学刊,2003,21(12)：1991-1992.
[8]刘征堂,金实,于佐文.中医药治疗干燥综合征的思路评析[J].中医药学刊,2004,22(9)：1714.
[9]杨梅玉,王莒生,李萍,等.王莒生治疗干燥综合征经验[J].北京中医药,2008,27(7)：506-508.
[10]王承德,沈丕安,胡荫奇.实用中医风湿病学[M].北京：人民卫生出版社,2009：334-336.
[11]路志正,焦树德.实用中医风湿病学[M].北京：人民卫生出版社,2001,466-476.
[12]董振华.活血化瘀法在干燥综合征中的应用[J].北京中医,2001,20(3):9-11.
[13]熊静,姚美玉,侯丽辉.阴阳双补治疗干燥综合征经验[J].长春中医药大学学报,2009,25(6)：857.
[14]汪悦.风湿病中医治疗[M].南京：江苏科学技术出版社,2005:345-346.
[15]赵振兴,侯绍敏.加味引火汤治疗干燥综合征15例临床观察[J].河北中医,1998,,20(3)：226-227.
[16]冯建华.干燥综合征的辨治[J].中国中医药信息杂志,1998(5)：41.
[17]张颖,马宗仁.中医治疗干燥综合征的经验总结[J].中外医疗,2008,(31) ：94.
[18]叶海军.从三焦论治干燥综合征[J].辽宁中医杂志,2004,31(6):477.
[19]刘志勤.中医三步治疗干燥综合征述要[J].中医药学刊,2005,23(3)：545.
[20]潘新.干燥综合征的中医诊治体会[J].湖北中医学院学报,2007,9(1):61-62.
[21]蔡凤信.滋阴润燥汤治疗干燥综合征46例[J].河北中医,2009,31(6):852-853.
[22]陈湘君,顾军花,茅建春,等.酸甘生津方对干燥综合征两种中医证型治疗作用研究[J].山东中医药大学学报,2007,31(4)：299-302.
[23]陈玲燕,王俊霞,杨森.润燥解毒汤治疗干燥综合征20例观察[J].临床荟萃,2010,25(2)：160-161.
[24]王海隆,张显彬.冯兴华治疗干燥综合征经验[J].中国中医药信息杂志,2007,14(5)：85.
[25]周翠英,潘文萍,王燕.燥毒清饮治疗干燥综合征临床研究[J].山东中医杂志,2005,24(12)：715-717.
[26]尹国富,岳敏,刘福华,等.养阴清热解毒汤治疗干燥综合征20例[J].中医研究,2010,23(2)：40-42.
[27]吴国琳,范永升.益气养阴祛瘀法治疗干燥综合征的临床疗效及其对免疫功能的影响[J].中国中西医结合杂志,2006,26(4)：322-324.
[28]韩善夯,金实,,刘征堂,等.宣肺布津颗粒治疗原发性干燥综合征38例临床研究[J].中国中医药信息杂志,2008,15(12)：14-16.
[29]周定华,张前德,魏睦新,等.丹地琼玉颗粒对干燥综合征小鼠唾液腺的影响[J].南京医科大学学报,2005,25(4)：266-267,272.
[30]申康,马洪玲,郭双敏,等.润燥口服液治疗原发性干燥综合征临床研究[J].河北医学,2006,12(2)：124-126.
[31]刘维,刘滨,郑红霞.针灸治疗干燥综合征60例疗效观察[J].中国针灸,2005,25(2)：101-102.
[32]白桦,于澎,于淼.电针对干燥综合征患者性激素水平影响的研究[J].针刺研究,2007,32(3)：203-206.
[33]郭凤芹,华红.干燥综合征的中医治疗进展[J].现代口腔医学杂志,2003,17(4)：359.
[34]王玲.中药配合针灸辨证治疗干燥综合征[J].中国中医药信息杂志,2007,14(12)：86-87.
[35]何庆勇,张吉.针药结合治疗干燥综合征23例[J].中国针灸,2007,1:43.
[36]古青,强世平,刘保成.针药并用治疗干燥综合征疗效观察[J].时珍国医国药,2008,19(1)：195-196.
[37]边晓东,王寿椿,罗开涛.针药结合治疗60例SS患者[J].山东中医杂志,2011,30(3)： 178-179.
[38]Wilder RL. Neuroimmunoendocrinology of the rheumatic diseases past present and future [J].Ann NYAcad Sci,2002,966:13-19.
[39]McMurray RW.Estroge, prolatin and autoimmunity action and interactions [J].Int Immunopharmacol,2001,1 (6):995-1008.
[40]Nagler RM, Pollack S. Sjogren's syndrome induced by estrogen therapy [J].Sem in Arthritis Rheum,2000,30 (3):209-214.
[41]Sato EH, Sullivan DA.Comparative influence of sterdid homones and immunosuppressive agents on autoimmune expression in acrimal glands of a female mouse model of Sjogren's syndrome [J].Invest Ophthalmol Vis Sci,1994,35: 2632-2642.
[42]Ahmed SA, Aufdem orte TB, Chen JR, et al. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates innormal mice [J]. Autoimmun,1989,2(4):543-552.
[43]Onodera K, Sasano H, Ichinohasama R, et al.Immunolo calization of aromatase in human minor salivary glands of the lower lip with primary Sjogren's syndrome [J].Pathol Int,1998,48 (10):786-790.
[44]Ho PC, Tang GWK, Lawton JWM. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after oestrogen replacement [J]. Human Reproduction,1993,8:714-716.
[45]Nilsson N, Carlsten H. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation [J]. Cell Immunol,1994, 158:131-139.
[46]Wang D, Chan EKL.17-β-estradiol increases expression of 52000 and 60000 SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7 [J]. J Invest Dermatol,1996,107:610-614.
[47]Ishimaru N, Arakaki R, Yoshida S, et al.Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy [J]. JExpMed,2008,205:2915-2927.
[48]Johnson EO, Skopouli FN, Moutsopoulos HM.Neuroendocrine manifestations in Sjogren's syndrome [J]. Rheum Dis Clin North Am,2000,26:927-949.
[49]彭清华,姚小磊,吴权龙,等.围绝经期性激素水平下降所致兔干眼症模型的建立[J].眼科新进展,2009,29(1)：5-11.
[50]Ishimaru N, Saegusa K, Yanagi K, et al. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis[J]. Am J Pathol,1999,155:173-181.
[51]潘卫红.围绝经期妇女灼口综合征与雌激素水平的相关性研究[J].中国妇幼保健,2009,24：122-123.
[52]Burger HGAndrogen production in women [J].Fertil Steril,2002 Apr,77 Suppl 4:S3-5.
[53]Porola P, Laine M, Virkki L, et al. The influence of sex steroids on Sjogren's syndrome [J]. Ann NY Acad Sci,2007,1108:426-432.
[54]Ono M, Rocha FJ, Sullivan DA.Immunocytochemical location andhormonal control of androgen receptors in lacrimal tissues of thefemale MRL/Mp-lpr/lpr mouse model of Sj ogren's syndrome [J]. Exp Eye Res,1995,61:659-666.
[55]Sullivan DA, Sato EH.Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjogren's syndrome [J].Clin Immunol Immunopathol,1992,64:9-16.
[56]Vendram ini ACLM, Soo C, Sullivan DA.Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model of Sjogren's syndrome [J].Invest Ophthalmol VisSci,1991,32:3002-3006.
[57]王建仓,卞小芸,宋秀君,等.去势雄兔干眼模型泪液分泌和泪膜稳定性的改变及局部雄激素治疗效果观察[J].河北医药,2008,30(5)：590-592.
[58]罗丰年,张汉承,孙叙清,等.去势雄兔泪液分泌及泪膜稳定性的改变[J].中华眼科杂志,2001,37(6)：458-461.
[59]Valtysdottir ST, Wide L, Hallgren R. Low serum dehydroep iandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function [J]. Rheuma tology,2001,28(6):1259-1265.
[60]Laine M, Porola P, Udby L, et al.Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome [J].Arthritis Rheum,2007,56:2575-2584.
[61]Forsblad-d EliaH, Carlsten H, Labrie F, et al.Low serum levels of sex-steroids are associated with disease characteristics in primary Sjogren's syndrome supplementation with dehydroepiandrosterone restores the concentrations [J].Clin Endocrinol Metah,2009,94(6):2044-2051.
[62]Porola P, Virkki L, Przybyla BD, et al.Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjogren's syndrome [J].Rheumatology,2008,35 (11):2229-2235.
[63]Sullivan DA, Belanger A, Cermak JM, et al.Are women with Sjogren's syndrome androgen-deficient[J].J Rheumatol,2003 Nov,30 (11):2413-2419.
[64]Krenzer KL, Dana MR, Uilman MD, et al.Effect of androgen deficiency on the human Meibomian gland and ocular surface [J]. Clin Endocrinol Metab, 2000,85(12):4874-4882.
[65]Cermak JM, Krenzer KL, Sullivan RM, et al. Is com plete androgen insensitivity syndrome associated with alterations in the Meibomian gland and ocular surface [J].Cornea,2003,22(6):512-516.
[66]Hartkamp A, Geenen R, Godaert GL, et al.2008 Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren's syndrome:a randomized controlled trial [J].Ann Rheum Dis,67:91-97.
[67]Pillemer SR, Brennan MT, Sankar V, et al.Fox PC 2004 Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome [J].Arthritis Rheum,51:601-604.
[68]Sullivan DA, Krenzer KL, Sullivan, et al.Invest Ophthalmol Vis Sci,1999 May,40 (6):1261-1265.
[69]张梅.干眼症的眼表改变及发病机制的研究进展[J].中国眼耳鼻喉科杂志,2002,2(4)：252-255.
[70]Nikolay P.Nikolov and Gabor Glllei.Pathogenesis of Sjogren's syndrome [J].Curr Opin Rheumatol,2009 September,21 (5):465-470.
[71]Taiym S, Haghighat N, Al-Hashimi LA comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2004 May; 97 (5):579-583.
[72]周建耀,刘佳,兰艳,等.女性原发性干燥综合征患者性激素水平[J].实用医技杂志,2007,14(28)：3931-3932.
[2]赵岩,董怡.原发性干燥综合征的临床分析[J].北京医学,1997,19(2):100-104.
[3]Manthorpe R.Primary Sjogren's syndrome:diagnosic criteria,clinical features and disease activity [J]..J Rhematol,1997,24(suppl):50.
[4]Tsubota K, Hirai S, King LS,et al.Defective cellular trafficking of lacrmal gland aquaporin-5 in Sjogren's syndrome [J].Lancet,2001,357(9257):688-689.
[5]Nikolay P. Nikolov and Gabor G. Illei. Pathogenesis of Sjogren's syndrome [J]. Current Opinion in Rheumatology 2009,21(5):465-470.
[6]Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren's syndrome [J].. ArchIntern Med.2004;164(12):1275-1284.
[7]王新昌,谢志军,温成平等.益气养阴祛瘀法治疗原发性干燥综合征的疗效观察[J].中国基层医学,2009(1):92-95.
[8]王新昌,谢志军,温成平等.益气养阴祛瘀药对干燥综合征患者性激素水平影响的研究[J].浙江中医药大学学报,2009(1):48-50.
[9]Fox RI, T heofilopoulos AN. Sjogren's syndrome:pathogensis and prospects for therapy [J]. Exp Opin Invest Drugs,1996,5:1.
[10]Gottenberg JE,Busson M,LoiseauP,etal.In primary Sjogren's syndrome,HLA classⅡ is associated exclusively with autoantibody production and spreading of the autoimmune response [J].Arthritis Rheum,2003,48(8):2240-2245.
[11]Fye KH,Terasaki PI,Moutspous H,et al.Assiciation of Sjogren's syndrome with HLA-B8 [J].Arthritis Rheum,1976,19:883.
[12]Johnson EO, Skopouli FN, Moutsopoulos HM. Neuroendocrine manifestations in Sjogren's syndrome [J]. Rheum Dis Clin North Am,2000,26 (4):927-949.
[13]孙文闻,巩路.雌激素在干燥综合征发病中的作用[J].国外医学内科学分册,2006,33(6)：245-248.
[14]Salem ML, Hossain MS, Nomoto K [J].Int Arch Allergy Immunol,2000,121 (3):235-245.
[15]张水艳.干燥综合征的中医病因病机及辨证治疗[J].中医杂志,2009,50(5)：468-470.
[16]Ishimaru N, Arakaki R, Yoshida S, et al. Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy [J]. J Exp Med 2008; 205:2915-2927.
[17]Nagler RM, Pollack S. Sjogren's syndrome induced by estrogen therapy [J]. Sem in Arthritis Rheum,2000 Dec;30(3):209-214.
[18]林良夫.雌激素水平下降引发干燥综合征[J].中华中医药学刊,2009,27(1)： 157.
[19]Konttinen YT, Fuellen G, Bing Y, et al. Sex steroids in Sjogren's syndrome [J]. J Autoimmun 2012 Aug; 39(1-2):49-56.
[20]Sullivan DA, Belanger A, Cermak JM,et al Are women with Sjogren's syndrome androgen-deficient [J]. J Rheumatol.2003 Nov; 30(11):2413-2419
[21]Beeson PB.Age and sex associations of 40 autoimmune disease [J].Am J Med,1994,96:457-462.
[22]Ishimaru N, Saegusa K, Yanagi K, Haneji N, Saito I, Hayashi Y:Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis [J]. Am J Pathol,1999,155:173-181.
[23]Sato TO, E.H.& D.A. Sullivan. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome [J]. Invest. Ophthalmol. Vis. Sci,1994,35: 2632-2642.
[24]Valtysdottir ST,et al. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function [J]. J. Rheumatol,2001,28:1259-1265.
[25]Laine M, Porola P, Udby L, et al. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome [J]. Arthritis Rheum.2007;56:2575-2584.
[26]Laine M. et al.2004. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome [J]. Arthritis Rheum.50:3968-3973.
[27]Taiym S, Haghighat N, Al-Hashimi I. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2004 May; 97(5):579-83.
[28]ITtah M, Miceli-Richard C, Gottenberg JE, et al. B-cell activating factor of the tumor necrosis factor family(BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome [J].Arthritis Res Ther, 2006,8:R51.
[29]Skapenko A, Schulze-Koops H.Analysis of Thl/Th2 T-cell subsets [J].Methods Mol Med,2007,136 (5):87-96.
[30]Liblau RS,Singer SM,McDevitt HO. Thl Aand Th2 CD4+ T-cell in the pathogenesis of organ-specific autoimmune disease [J].Immunol Today,1995,16: 34-38.
[31]唐福林.原发性干燥综合征的发病机制[J].中华风湿病学杂志,2000,4(1):50-53.
[32]蒋明,David YU,林孝义,等.中国风湿病学[M].北京：华夏出版社,2004,8：845.
[33]卢家俐,赵铖.羟基氯喹在风湿性疾病中的应用进展[J]. Internal Medicine of China,2008,3(1):69-70.
[34]Dawson LJ, Caulfied VL, Stanbury JB, et al.Hydroxychloroquine therapy in patients with primary Sjogren's syndrome may improve salivary gland Hypofunotion by inhibition of glangular cholinesterase [J].Rh eum atology,2005,44 (4):449-455.
[35]帅世全,孙红兵.羟氯喹治疗原发性干燥综合征的临床观察[J].西部医学,2011.23(7)：1281-1283.
[36]路志正,焦树德.痹病论治学[M].北京：人民卫生出版社,1989：281.
[37]姜泉,殷海波,张香妮,等.78例原发性干燥综合征患者中医证候分析[J].中华中医药杂志,2011,26(10):2402-2404.
[38]郝伟欣,董振华.干燥综合征106例中医证候分类回顾性研究[J].中医杂志,2006,(7)：528-529.
[39]宁康健,阮样春,吕锦芳.黄芪对小鼠腹腔巨噬细胞吞噬能力的影响[J].中国中药杂志,2005.30(21)：1670-1672.
[40]赵磊,蒲小平.丹参粉针剂对大鼠心肌缺血/再灌注损伤的保护作用[J].中国新药杂志,2006,15(14)：39-41.
[41]李嫒,宋宝安,杨松,等.中草药玄参化学成分的研究[J].天然产物研究与开发,2012,,24：47-51.
[42]王洪志,刘朝东,韦超.白芍总苷对慢性非细菌性前列腺炎大鼠IFN-γ、 TNF-a和IL-10表达影响的实验研究[J].重庆医科大学学报,2010,35(2)：231-234.
[43]韩凤梅,刘春霞,陈勇.麦冬多糖对免疫低下小鼠的保护作用[J].中国医药学报,2004,19(6)：347.
[44]沈玉先,魏伟,徐叔云,等.白芍总甙的药理作用及机制[A].吴曙光.抗炎免疫药理学进展[M].上海：第二军医大学出版社,1997.162-167.
[45]梁君山,魏伟,周爱武.白细胞介素1的检测及白芍总甙对其产生的影响[J].中国药理学通报,1989,5(6)：354-357.
[46]查学强,王军辉,潘利华,等.石斛多糖体外抗氧化活性的研究[J].食品科学,2007,28(10)：90-93.
[47]李钦,陈爱君,张信岳.铁皮石斛颗粒增强免疫功能作用研究[J].中药药理与临床,2008,24(1)：53-55.
[48]叶庆华,赵维民,秦国伟.石斛属植物化学成分及生物活性研究进展[J].药物化学进展,2004(3)：113.
[49]陈照荣,来平凡,林巧,等.不同炮制方法对石斛中石斛碱和多糖溶出率的影响[J].浙江中医学院学报,2002,26(4)：79.
[50]徐杭民,侯家玉.中药药理学[M].北京：中国中医药出版社,2002:157-158.
[51]Yoshiyo H, Mitsunobu S, Katsuiku H.Induction of experimental allergic sialodenitis in mice [J].Am J Pathol,1985,118:476-483.
[52]Greiner DL, Angelillo M, Wayne AL, et al.Experimental autoallergic sialodenitis in the LEW rat.Ⅲ Role of CD4+ T cells in EAS induction [J].Cell Immunol,1991,135:354-359.
[53]Mya Mu, Dipshikha C, Kazuko T, et al.Production of experimental autoimmune sialodenitis in mice immunized with homologous salivary gland extract and klebsiella O3 lipopolysaccharide [J].J Autoimmunity,2001,16:29-36.
[54]Suzuki K, Makino M, Okada Y, et al.Exocrinopathy resembling Sjogren's syndrome induced by a murine retrovirus[J].Lab Invest,1993,69:430-435.
[55]Yoshiyo H, Yashiaki Y, Hideo Y, et al.Development of allergic sialodenitis in mice immunized with mumps virus-infected submandibular salivary gland [J].Am J Pathol,1986,123:271-279.
[56]Van Blokland SC, Van Helden-Meeuwsen CG, Wierenga-Wolf AF, et al.Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjogren's syndrome:limited role for apoptosis in the development of sialoadenitis [J].Lab Invest,2003Jan,83 (1):3-11.
[57]Humphrey-Beher MG, Hu Y, Nakagawa Y, Wang PL, et al.Utilization of then non-obese diabetic(NOD) mouse as an animal model for the study of secondary Sjogren's syndrome [J].Adv Exp Med Biol,1994,350:631-636.
[58]Yamano S, Atkinson JC, Baum BJ, et al. salivary gland cytokine gene expression in NOD and BALB/c mice [J].Autoimmunity,1999,92,:265-275.
[59]Cha S, Peck AB, Humphreys-Beher MG, et al.Progress in understanding autoimmune exoc finopathy using the non-obese diabetic mouse:anupate [J].Cfit Rev Oral Biol Med,2002,13 (1):5-16.
[60]颜淑敏,曾小峰.原发性干燥综合征诊治进展[J].实用医院临床杂志,2007(3)：6-8.
[61]黄桂红,黄纯真,黄仁彬.阳桃根多糖对糖尿病小鼠胰岛素及胸、脾指数的影响[J].2009,,12(7)：848-850.
[62]曾靖,邱峰.大豆苷元对免疫器官的影响[J].赣南医学院学报,2004,24(2)：117-118.
[63]Rock F,Hardiman G,Timans J, et al. A family of human receptors structurally related to Drosophila Toll [J]. Proc Natl Acad Sci,1998,95 (2):588-593.
[64]Hans M,Hans V M.Toll-like receptors and their dual role in periodontitis:a review [J].J Oral Sci,2011,53 (3):263-271.
[65]Pasare C,Medzhitov R.Toll-like receptors:linking innate and adaptiveimmunity [J].Adv Exp Med Biol,2005,560:11-18.
[66]Werling D,Jann O C,Offord V,et al. Variation matters:TLR structure and species-specific pathogen recognition [J].Trends Immunol,2009,30(3):124-130.
[67]Runblom L, Alm GV. An etiopathogenic role for the type I IFN system in SLE [J]. Trends Immunol,2001,22(8):427-431.
[68]Hunziker L, Recher M, Macpherson AJ, et al. Hypergammaglobu-linemia and autoantibody induction mechanisms in viral infections [J].Nat Immunol,2003,4(4):343-349.
[69]KawakamiA, NakashimaK, TaxnaiM, et al. Toll-like receptor in salivary glands from Patients with Sjogren's syndrome:functional analysis by human salivary glands cell line [J]. J Rheumatol,2007,34(5):1019-1026.
[70]SPaehidouMP,BourazoPoulou E, Maratheftis Cl, et al. Expression of functional Toll-like Receptors by salivary gland epithelial cells:increased mRNA expression in cells derived from Patients with Primary Sjogren's syndrome [J]. Clin ExP immunol.2007,147(3):497-503.
[71]Ronnblom L,Gunnar VA. A pivotal role for the natural interferon-a-pro-ducing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus cing cells [J].J Exp Med,2001,12:F59-F63.
[72]Bave U, Nordmark G, Lovgren T, et al. Activation of the type I interferon system in primary Sjogren's syndrome:a possible etiopathogenic mechanism [J]. Arthritis Rheum 2005; 52:1185-1195.
[73]Hjelmervik TO, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy controls [J]. Arthritis Rheum 2005; 52:1534-1544.
[74]Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome [J]. Proc Natl Acad Sci U S A 2006; 103:2770-2775.
[75]Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjogren's syndrome [J]. Genes Immun 2009; 10:285-296.
[76]Lavie F, Miceli-Richard C, Ittah M, et al. -cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren's syndrome [J].Scand J Immunol,2008,67(2):185-192.
[77]Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome [J].Arthritis Rheum,2007,56(11):3588-3600.
[78]Mavragani CP, Niewold TB, Moutsopoulos NM, et al. Augmented interferon- alpha pathway activation in patients with Sjogren's syndrome treated with etanercept [J].Arthritis Rheum,2007,56(12):3995-4004.
[79]Moore PA,Belvedere 0,0 rr A,el al. BLyS:member of the tumor necrosis factor family and B lymphocyte stimulator [J].Science,1999,285(5425):260-263.
[80]Mackay F, Figgett WA, Saulep D, et al. B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor [J].Immunol Rev,2010,237(1):205-225.
[81]Groom J,Kalled SL,Cutler AH, et al. association of BAFF/BLyS over-expression and altered B cell differentiation with Sjogren's syndrome [J].J.Clin.Invest.2002,109(1):59-68.
[82]Szodoray P, Jellestad S, Teague MO, et al. Attenuated apoptosis of B cell activating factor-expressing cell in primary Sjogren's syndrome [J].Lab Invest,2003, 83(3):357-365.
[83]Lavie F,Miceli-Richacd C,QlIillard J,et a 1.Expression of BAFF in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome [J].J PatIlol,2004,202:496-502.
[84]Mariette x,Roux S,Zhang J,et al. The level of BlyS(BAFF) correlates with the tire of autoantibodies in human Sjogren's syndrome [J].Ann Rheum Dis,2003,62:168-171.
[85]Candon S, Gottenberg JE, Bengoufa D, et al. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren's syndrome:correlation with B-cell biomarkers and disease activity [J].Ann Rheum Dis,2009,68(7):1208-1212.
[86]Fox RI. Sjogren's syndrome [J].Lancet,2005,366(9482):321-331.
[87]Nikolov NP, Illei GG, Pathogenesis of Sjogren's syndrome [J].Curr Opin Rheumatol,2009;21(5):465-470.
[88]James J A, Harley J B, Scofield R H, Role of virus in systemic lupus erythematosus and Sjogren's syndrome[J]. Curr Opin Rheumatol,2001;13(5):370-376.
[89]Gujer C, Sundling C, Seder R A, et al. Human and rhesus plasmacytoid dendrtic cell and B-cell responses to Toll-like receptor stimulation [J].Immunology, 2011,134(3):257-269.
[90]Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type I interferon-producing cells in human blood [J]. Science 1999;284:1835-7.
[91]Perl A. Pathogenic mechanisms in systemic lupus erythematosus [J].Autoimmunity,2010,43(1):1-6.
[92]Komatsuda A, Wakui H, Iwamoto K, et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemi lupus erythematosus [J].Clin Exp Immunol,2008,152(3):482-487.
[93]Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, et al. Systemic increase in type I interferon activity in Sjogren's syndrome:a putative role for plasmacytoid dendritic cells [J]. Eur J Immunol,2008,38:2024-2033.
[94]Zhou L,Zhong R,Hao W,et al.Interleukin-10 and interferon-gamma up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells [J].Exp Mol Pathol,2009,87(1):54-58.
[95]Ittah M, Miceli-Richard C, Eric Gottenberg J, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome [J].Arthritis Res Ther,2006,8(2):51.
[96]Tobon GJ, Pers JO, Youinou P, et al. B cell-targeted therapies in Sjogren's syndrome [J].Autoimmun Rev,2010,9(4):224-228.
[1]Fox RI. Sjogren's syndrome [J].Lancet,2005,366:321-331.
[2]Shen Hu, Jianghua Wang, Jiska Meijer, etal.Salivary Proteomic and Genomic Biomarkers for Primary Sjogren's syndrome [J].Arthri-tisRheum,2007 November, 56 (11):3588-3600.
[3]Venables PJW.Sjogren's syndrome.Best Practice and Research [J].Clinical Rheumatology,2004,18 (3):313-329.
[4]钱垠,金实.从肺论治干燥综合征[J].南京中医药大学学报,2002,18(5):268-269.
[5]母小真.陈湘君治疗干燥综合征的经验[J].辽宁中医杂志,2002,29(1)：11.
[6]谢幼红.从脾论治干燥综合征的探讨[J].陕西中医,2010,31(6):710-711.
[7]陆瑾.陆安康教授治疗干燥综合征经验精粹[J].中医药学刊,2003,21(12)：1991-1992.
[8]刘征堂,金实,于佐文.中医药治疗干燥综合征的思路评析[J].中医药学刊,2004,22(9)：1714.
[9]杨梅玉,王莒生,李萍,等.王莒生治疗干燥综合征经验[J].北京中医药,2008,27(7)：506-508.
[10]王承德,沈丕安,胡荫奇.实用中医风湿病学[M].北京：人民卫生出版社,2009：334-336.
[11]路志正,焦树德.实用中医风湿病学[M].北京：人民卫生出版社,2001,466-476.
[12]董振华.活血化瘀法在干燥综合征中的应用[J].北京中医,2001,20(3):9-11.
[13]熊静,姚美玉,侯丽辉.阴阳双补治疗干燥综合征经验[J].长春中医药大学学报,2009,25(6)：857.
[14]汪悦.风湿病中医治疗[M].南京：江苏科学技术出版社,2005:345-346.
[15]赵振兴,侯绍敏.加味引火汤治疗干燥综合征15例临床观察[J].河北中医,1998,,20(3)：226-227.
[16]冯建华.干燥综合征的辨治[J].中国中医药信息杂志,1998(5)：41.
[17]张颖,马宗仁.中医治疗干燥综合征的经验总结[J].中外医疗,2008,(31) ：94.
[18]叶海军.从三焦论治干燥综合征[J].辽宁中医杂志,2004,31(6):477.
[19]刘志勤.中医三步治疗干燥综合征述要[J].中医药学刊,2005,23(3)：545.
[20]潘新.干燥综合征的中医诊治体会[J].湖北中医学院学报,2007,9(1):61-62.
[21]蔡凤信.滋阴润燥汤治疗干燥综合征46例[J].河北中医,2009,31(6):852-853.
[22]陈湘君,顾军花,茅建春,等.酸甘生津方对干燥综合征两种中医证型治疗作用研究[J].山东中医药大学学报,2007,31(4)：299-302.
[23]陈玲燕,王俊霞,杨森.润燥解毒汤治疗干燥综合征20例观察[J].临床荟萃,2010,25(2)：160-161.
[24]王海隆,张显彬.冯兴华治疗干燥综合征经验[J].中国中医药信息杂志,2007,14(5)：85.
[25]周翠英,潘文萍,王燕.燥毒清饮治疗干燥综合征临床研究[J].山东中医杂志,2005,24(12)：715-717.
[26]尹国富,岳敏,刘福华,等.养阴清热解毒汤治疗干燥综合征20例[J].中医研究,2010,23(2)：40-42.
[27]吴国琳,范永升.益气养阴祛瘀法治疗干燥综合征的临床疗效及其对免疫功能的影响[J].中国中西医结合杂志,2006,26(4)：322-324.
[28]韩善夯,金实,,刘征堂,等.宣肺布津颗粒治疗原发性干燥综合征38例临床研究[J].中国中医药信息杂志,2008,15(12)：14-16.
[29]周定华,张前德,魏睦新,等.丹地琼玉颗粒对干燥综合征小鼠唾液腺的影响[J].南京医科大学学报,2005,25(4)：266-267,272.
[30]申康,马洪玲,郭双敏,等.润燥口服液治疗原发性干燥综合征临床研究[J].河北医学,2006,12(2)：124-126.
[31]刘维,刘滨,郑红霞.针灸治疗干燥综合征60例疗效观察[J].中国针灸,2005,25(2)：101-102.
[32]白桦,于澎,于淼.电针对干燥综合征患者性激素水平影响的研究[J].针刺研究,2007,32(3)：203-206.
[33]郭凤芹,华红.干燥综合征的中医治疗进展[J].现代口腔医学杂志,2003,17(4)：359.
[34]王玲.中药配合针灸辨证治疗干燥综合征[J].中国中医药信息杂志,2007,14(12)：86-87.
[35]何庆勇,张吉.针药结合治疗干燥综合征23例[J].中国针灸,2007,1:43.
[36]古青,强世平,刘保成.针药并用治疗干燥综合征疗效观察[J].时珍国医国药,2008,19(1)：195-196.
[37]边晓东,王寿椿,罗开涛.针药结合治疗60例SS患者[J].山东中医杂志,2011,30(3)： 178-179.
[38]Wilder RL. Neuroimmunoendocrinology of the rheumatic diseases past present and future [J].Ann NYAcad Sci,2002,966:13-19.
[39]McMurray RW.Estroge, prolatin and autoimmunity action and interactions [J].Int Immunopharmacol,2001,1 (6):995-1008.
[40]Nagler RM, Pollack S. Sjogren's syndrome induced by estrogen therapy [J].Sem in Arthritis Rheum,2000,30 (3):209-214.
[41]Sato EH, Sullivan DA.Comparative influence of sterdid homones and immunosuppressive agents on autoimmune expression in acrimal glands of a female mouse model of Sjogren's syndrome [J].Invest Ophthalmol Vis Sci,1994,35: 2632-2642.
[42]Ahmed SA, Aufdem orte TB, Chen JR, et al. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates innormal mice [J]. Autoimmun,1989,2(4):543-552.
[43]Onodera K, Sasano H, Ichinohasama R, et al.Immunolo calization of aromatase in human minor salivary glands of the lower lip with primary Sjogren's syndrome [J].Pathol Int,1998,48 (10):786-790.
[44]Ho PC, Tang GWK, Lawton JWM. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after oestrogen replacement [J]. Human Reproduction,1993,8:714-716.
[45]Nilsson N, Carlsten H. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation [J]. Cell Immunol,1994, 158:131-139.
[46]Wang D, Chan EKL.17-β-estradiol increases expression of 52000 and 60000 SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7 [J]. J Invest Dermatol,1996,107:610-614.
[47]Ishimaru N, Arakaki R, Yoshida S, et al.Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy [J]. JExpMed,2008,205:2915-2927.
[48]Johnson EO, Skopouli FN, Moutsopoulos HM.Neuroendocrine manifestations in Sjogren's syndrome [J]. Rheum Dis Clin North Am,2000,26:927-949.
[49]彭清华,姚小磊,吴权龙,等.围绝经期性激素水平下降所致兔干眼症模型的建立[J].眼科新进展,2009,29(1)：5-11.
[50]Ishimaru N, Saegusa K, Yanagi K, et al. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis[J]. Am J Pathol,1999,155:173-181.
[51]潘卫红.围绝经期妇女灼口综合征与雌激素水平的相关性研究[J].中国妇幼保健,2009,24：122-123.
[52]Burger HGAndrogen production in women [J].Fertil Steril,2002 Apr,77 Suppl 4:S3-5.
[53]Porola P, Laine M, Virkki L, et al. The influence of sex steroids on Sjogren's syndrome [J]. Ann NY Acad Sci,2007,1108:426-432.
[54]Ono M, Rocha FJ, Sullivan DA.Immunocytochemical location andhormonal control of androgen receptors in lacrimal tissues of thefemale MRL/Mp-lpr/lpr mouse model of Sj ogren's syndrome [J]. Exp Eye Res,1995,61:659-666.
[55]Sullivan DA, Sato EH.Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjogren's syndrome [J].Clin Immunol Immunopathol,1992,64:9-16.
[56]Vendram ini ACLM, Soo C, Sullivan DA.Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model of Sjogren's syndrome [J].Invest Ophthalmol VisSci,1991,32:3002-3006.
[57]王建仓,卞小芸,宋秀君,等.去势雄兔干眼模型泪液分泌和泪膜稳定性的改变及局部雄激素治疗效果观察[J].河北医药,2008,30(5)：590-592.
[58]罗丰年,张汉承,孙叙清,等.去势雄兔泪液分泌及泪膜稳定性的改变[J].中华眼科杂志,2001,37(6)：458-461.
[59]Valtysdottir ST, Wide L, Hallgren R. Low serum dehydroep iandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function [J]. Rheuma tology,2001,28(6):1259-1265.
[60]Laine M, Porola P, Udby L, et al.Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome [J].Arthritis Rheum,2007,56:2575-2584.
[61]Forsblad-d EliaH, Carlsten H, Labrie F, et al.Low serum levels of sex-steroids are associated with disease characteristics in primary Sjogren's syndrome supplementation with dehydroepiandrosterone restores the concentrations [J].Clin Endocrinol Metah,2009,94(6):2044-2051.
[62]Porola P, Virkki L, Przybyla BD, et al.Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjogren's syndrome [J].Rheumatology,2008,35 (11):2229-2235.
[63]Sullivan DA, Belanger A, Cermak JM, et al.Are women with Sjogren's syndrome androgen-deficient[J].J Rheumatol,2003 Nov,30 (11):2413-2419.
[64]Krenzer KL, Dana MR, Uilman MD, et al.Effect of androgen deficiency on the human Meibomian gland and ocular surface [J]. Clin Endocrinol Metab, 2000,85(12):4874-4882.
[65]Cermak JM, Krenzer KL, Sullivan RM, et al. Is com plete androgen insensitivity syndrome associated with alterations in the Meibomian gland and ocular surface [J].Cornea,2003,22(6):512-516.
[66]Hartkamp A, Geenen R, Godaert GL, et al.2008 Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren's syndrome:a randomized controlled trial [J].Ann Rheum Dis,67:91-97.
[67]Pillemer SR, Brennan MT, Sankar V, et al.Fox PC 2004 Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome [J].Arthritis Rheum,51:601-604.
[68]Sullivan DA, Krenzer KL, Sullivan, et al.Invest Ophthalmol Vis Sci,1999 May,40 (6):1261-1265.
[69]张梅.干眼症的眼表改变及发病机制的研究进展[J].中国眼耳鼻喉科杂志,2002,2(4)：252-255.
[70]Nikolay P.Nikolov and Gabor Glllei.Pathogenesis of Sjogren's syndrome [J].Curr Opin Rheumatol,2009 September,21 (5):465-470.
[71]Taiym S, Haghighat N, Al-Hashimi LA comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2004 May; 97 (5):579-583.
[72]周建耀,刘佳,兰艳,等.女性原发性干燥综合征患者性激素水平[J].实用医技杂志,2007,14(28)：3931-3932.